Welcome to our dedicated page for Rentokil Initial Plc SEC filings (Ticker: RTO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for Rentokil Initial plc (NYSE: RTO) provides access to the company’s U.S. regulatory disclosures, including its annual report on Form 20-F and current reports on Form 6-K. As a foreign private issuer and UK-listed company, Rentokil Initial uses these filings to share information with U.S. investors about its global pest control, hygiene and wellbeing operations.
Form 20-F contains detailed information about the group’s business activities, risk factors, governance and financial reporting. For a company operating in around 90 countries and employing more than 60,000 people, this document is a key resource for understanding the structure and scope of its pest control and hygiene services, as well as its North American operations under the Rentokil Terminix brand.
Form 6-K current reports are used to furnish important information that Rentokil Initial releases in other markets. Examples in the available data include notifications of major shareholdings, directorate changes and announcements that the Annual Report and Financial Statements and AGM notices have been filed with the UK Financial Conduct Authority and made available via the National Storage Mechanism. Some 6-K filings also cover matters such as director and related party share dealings in the company’s American Depositary Shares.
On Stock Titan, these filings are updated as they are released through EDGAR and can be paired with AI-powered summaries to help explain complex sections in clearer language. This can be particularly useful when reviewing topics such as major shareholder notifications, governance changes or the structure of Rentokil Initial’s ADS programme, where each ADS represents five ordinary shares. The filings page is therefore a central reference point for investors and researchers seeking a regulatory view of RTO’s global business services operations.
GIC Private Limited has filed an amended ownership report showing a 4.42% stake in Rentokil Initial plc. GIC reports beneficial ownership of 111,603,741 ordinary shares of Rentokil Initial, based on 2,526,039,885 shares of common stock outstanding.
GIC has sole voting and dispositive power over 53,934,471 shares and shares voting and dispositive power over 57,669,270 shares, including holdings managed for the Government of Singapore and the Monetary Authority of Singapore. GIC certifies the shares are not held to change or influence control of Rentokil Initial.
BlackRock Portfolio Management LLC, a Delaware entity, reports beneficial ownership of 128,274,784 Rentokil Initial PLC common shares, representing 5.1% of the class as of 12/31/2025.
The firm has sole power to vote 118,396,212 shares and sole power to dispose of all 128,274,784 shares, with no shared voting or dispositive power. Various underlying clients have rights to dividends or sale proceeds, but no single client holds more than five percent of Rentokil’s outstanding common shares.
The shares are described as acquired and held in the ordinary course of business, and not for the purpose of changing or influencing control of Rentokil Initial PLC.
Rentokil Initial plc has reported a change in a major shareholding position via a TR-1 notification. A shareholder’s total voting interest has moved to 4.98% of voting rights, all held through ordinary shares with ISIN GB00B082RF11. This represents 125,795,910 voting rights now held in the company.
The holding was previously disclosed at 5.01% of voting rights, so the latest notification reflects a small reduction that takes the position just below the 5% disclosure threshold. The update does not involve any financial instruments such as options or other derivatives, as all notified voting rights are attached directly to shares.
Rentokil Initial plc reports a change in a major shareholding after a holder crossed a UK disclosure threshold. The investor now controls 5.010000% of the voting rights, corresponding to 126,470,698 voting rights attached to shares. This stake was previously 4.908100%, so the change reflects a modest increase in ownership. All voting rights are held through shares, with no additional exposure reported via financial instruments.
Rentokil Initial plc has reported a change in a major shareholding based on a TR-1 notification. GIC Private Limited now holds a total of 4.226956% of Rentokil Initial’s voting rights, corresponding to 106,774,597 voting rights, after crossing a disclosure threshold on 9 January 2026. This compares with a previously notified position of 4.958379%.
The new position includes 3.939112% of voting rights attached to shares and 0.287844% held through financial instruments in the form of lent securities. The notification also outlines the chain of controlled undertakings through which GIC’s investment entities hold these interests, with GIC retaining full discretion over how voting power is exercised through certain subsidiaries.
Rentokil Initial plc has appointed Mike Duffy as Chief Executive and Executive Director, effective 16 March 2026, with him joining on 16 February 2026 as CEO Designate. He succeeds Andy Ransom, who will step down as CEO and Executive Director on 16 March 2026 and support a smooth transition through the AGM on 7 May 2026. Duffy, a US-based executive, brings more than 25 years of leadership experience across logistics, truck parts distribution, grocery wholesale and healthcare supply chains.
His remuneration includes an annual salary of US$1,600,000, an annual bonus opportunity up to 225% of base salary, and long-term incentive plan awards up to 375% of base salary, alongside standard benefits and pension. Rentokil Initial will also compensate him for forfeited 2025 bonus and long-term incentives through cash and three replacement share awards with a combined maximum grant date value of US$3.98m, all subject to clawback and malus. The company plans to announce its full-year 2025 financial results on 5 March 2026, with Ransom and CFO Paul Edgecliffe-Johnson presenting before the leadership handover.
Rentokil Initial plc reported that the Samuel J. Mitchell, Jr. Revocable Trust, which is closely associated with non-executive director Samuel Mitchell, purchased 30 American Depositary Shares (ADSs) of the company on 11 August 2025. The ADSs were bought at a price of USD 25.12 per ADS on the New York Stock Exchange.
Each ADS represents five ordinary shares of one pence each in the capital of Rentokil Initial plc. Following this transaction, Samuel Mitchell’s total beneficial ownership in the company is 120 ADSs. The disclosure has been made in line with the requirements of Article 19 of the UK Market Abuse Regulation.
Rentokil Initial plc has reported a change in a major shareholding under a TR-1 notification, as furnished on a Form 6-K. A shareholder crossed a disclosure threshold and now holds 3.020865% of Rentokil Initial’s voting rights, corresponding to 76,308,258 voting rights attached to ordinary shares with ISIN GB00B082RF11.
The disclosed position consists entirely of voting rights attached to shares, with no additional voting rights held through financial instruments. This type of notice is a regulatory transparency requirement and indicates an updated ownership level but does not, by itself, describe any transaction terms or changes to Rentokil Initial’s operations or finances.
Rentokil Initial plc reported a notification of major holdings from GIC Private Limited, a Singapore-based investment firm. GIC’s total interest in Rentokil now represents 4.958379% of the company’s voting rights, equal to 125,250,650 voting rights on the date the threshold was crossed.
Of this, 4.670535% of voting rights (117,979,594 voting rights) are attached to ordinary shares, split between direct and indirect holdings, while a further 0.287844% (7,271,056 voting rights) arises from lent securities classified as financial instruments. GIC’s position was previously notified at a higher total of 5.241261%, indicating a reduction that took the holding across a regulatory threshold, requiring this disclosure.
Janus Henderson Group plc filed Amendment No. 4 to Schedule 13G reporting beneficial ownership of 142,436,808 shares of Rentokil Initial plc common stock, representing 5.6% of the class. The filing shows shared voting and shared dispositive power over 142,436,808 shares and no sole power.
Separately, Janus Henderson Investors US LLC (JHIUS) may be deemed the beneficial owner of 127,304,380 shares, or 5.0%, with shared voting and dispositive power. The certification states the securities were acquired and are held in the ordinary course and not for the purpose of changing or influencing control.
FAQ
What is the current stock price of Rentokil Initial Plc (RTO)?
What is the market cap of Rentokil Initial Plc (RTO)?
